Limit/Sort Search Search as Words
     
Limit search to available items
Nearby Subjects are:
Result Page   Prev Next
Add Marked to Bag Add All On Page Add Marked to My Lists
Mark   Year Entries
Meningitis in children.   2
Meningitis -- Laboratory manuals : Meningococcal vaccines : methods and protocols / edited by Andrew J. Pollard and Martin C.J. Maiden ; foreword by E. Richardson Moxon  2001 1
Meningitis, Meningococcal.   5
Meningitis, Meningococcal -- diagnosis : Meningococcal disease : methods and protocols / edited by Andrew J. Pollard and Martin C.J. Maiden  2001 1
Meningitis, Meningococcal -- prevention & control. : Guidelines for the control of meningococcal disease in Australia : endorsed October 1996 by the National Health and Medical Research Council  1996 1
 

Meningitis, Meningococcal, Serogroup A -- See Meningitis, Meningococcal


A fulminant infection of the meninges and subarachnoid fluid by the bacterium NEISSERIA MENINGITIDIS, producing diffuse inflammation and peri-meningeal venous thromboses. Clinical manifestations include FEVER, nuchal rigidity, SEIZURES, severe HEADACHE, petechial rash, stupor, focal neurologic deficits, HYDROCEPHALUS, and COMA. The organism is usually transmitted via nasopharyngeal secretions and is a leading cause of meningitis in children and young adults. Organisms from Neisseria meningitidis serogroups A, B, C, Y, and W-135 have been reported to cause meningitis. (From Adams et al., Principles of Neurology, 6th ed, pp689-701; Curr Opin Pediatr 1998 Feb;10(1):13-8) 		  1
 

Meningitis, Meningococcal, Serogroup B -- See Meningitis, Meningococcal


A fulminant infection of the meninges and subarachnoid fluid by the bacterium NEISSERIA MENINGITIDIS, producing diffuse inflammation and peri-meningeal venous thromboses. Clinical manifestations include FEVER, nuchal rigidity, SEIZURES, severe HEADACHE, petechial rash, stupor, focal neurologic deficits, HYDROCEPHALUS, and COMA. The organism is usually transmitted via nasopharyngeal secretions and is a leading cause of meningitis in children and young adults. Organisms from Neisseria meningitidis serogroups A, B, C, Y, and W-135 have been reported to cause meningitis. (From Adams et al., Principles of Neurology, 6th ed, pp689-701; Curr Opin Pediatr 1998 Feb;10(1):13-8) 		  1
 

Meningitis, Meningococcal, Serogroup C -- See Meningitis, Meningococcal


A fulminant infection of the meninges and subarachnoid fluid by the bacterium NEISSERIA MENINGITIDIS, producing diffuse inflammation and peri-meningeal venous thromboses. Clinical manifestations include FEVER, nuchal rigidity, SEIZURES, severe HEADACHE, petechial rash, stupor, focal neurologic deficits, HYDROCEPHALUS, and COMA. The organism is usually transmitted via nasopharyngeal secretions and is a leading cause of meningitis in children and young adults. Organisms from Neisseria meningitidis serogroups A, B, C, Y, and W-135 have been reported to cause meningitis. (From Adams et al., Principles of Neurology, 6th ed, pp689-701; Curr Opin Pediatr 1998 Feb;10(1):13-8) 		  1
 

Meningitis, Meningococcal, Serogroup W-135 -- See Meningitis, Meningococcal


A fulminant infection of the meninges and subarachnoid fluid by the bacterium NEISSERIA MENINGITIDIS, producing diffuse inflammation and peri-meningeal venous thromboses. Clinical manifestations include FEVER, nuchal rigidity, SEIZURES, severe HEADACHE, petechial rash, stupor, focal neurologic deficits, HYDROCEPHALUS, and COMA. The organism is usually transmitted via nasopharyngeal secretions and is a leading cause of meningitis in children and young adults. Organisms from Neisseria meningitidis serogroups A, B, C, Y, and W-135 have been reported to cause meningitis. (From Adams et al., Principles of Neurology, 6th ed, pp689-701; Curr Opin Pediatr 1998 Feb;10(1):13-8) 		  1
 

Meningitis, Meningococcal, Serogroup W135 -- See Meningitis, Meningococcal


A fulminant infection of the meninges and subarachnoid fluid by the bacterium NEISSERIA MENINGITIDIS, producing diffuse inflammation and peri-meningeal venous thromboses. Clinical manifestations include FEVER, nuchal rigidity, SEIZURES, severe HEADACHE, petechial rash, stupor, focal neurologic deficits, HYDROCEPHALUS, and COMA. The organism is usually transmitted via nasopharyngeal secretions and is a leading cause of meningitis in children and young adults. Organisms from Neisseria meningitidis serogroups A, B, C, Y, and W-135 have been reported to cause meningitis. (From Adams et al., Principles of Neurology, 6th ed, pp689-701; Curr Opin Pediatr 1998 Feb;10(1):13-8) 		  1
 

Meningitis, Meningococcal, Serogroup Y -- See Meningitis, Meningococcal


A fulminant infection of the meninges and subarachnoid fluid by the bacterium NEISSERIA MENINGITIDIS, producing diffuse inflammation and peri-meningeal venous thromboses. Clinical manifestations include FEVER, nuchal rigidity, SEIZURES, severe HEADACHE, petechial rash, stupor, focal neurologic deficits, HYDROCEPHALUS, and COMA. The organism is usually transmitted via nasopharyngeal secretions and is a leading cause of meningitis in children and young adults. Organisms from Neisseria meningitidis serogroups A, B, C, Y, and W-135 have been reported to cause meningitis. (From Adams et al., Principles of Neurology, 6th ed, pp689-701; Curr Opin Pediatr 1998 Feb;10(1):13-8) 		  1
Meningitis, Meningococcal -- therapy : Meningococcal disease : methods and protocols / edited by Andrew J. Pollard and Martin C.J. Maiden  2001 1
 

Meningitis, Meningococcic -- See Meningitis, Meningococcal


A fulminant infection of the meninges and subarachnoid fluid by the bacterium NEISSERIA MENINGITIDIS, producing diffuse inflammation and peri-meningeal venous thromboses. Clinical manifestations include FEVER, nuchal rigidity, SEIZURES, severe HEADACHE, petechial rash, stupor, focal neurologic deficits, HYDROCEPHALUS, and COMA. The organism is usually transmitted via nasopharyngeal secretions and is a leading cause of meningitis in children and young adults. Organisms from Neisseria meningitidis serogroups A, B, C, Y, and W-135 have been reported to cause meningitis. (From Adams et al., Principles of Neurology, 6th ed, pp689-701; Curr Opin Pediatr 1998 Feb;10(1):13-8) 		  1
Meningitis -- Molecular aspects -- Laboratory manuals : Meningococcal disease : methods and protocols / edited by Andrew J. Pollard and Martin C.J. Maiden  2001 1
Meningitis -- Prevention : Meningitis and encephalitis : management and prevention challenges / Rodrigo Hasbun, editor  2018 1
Meningitis -- prevention & control : Meningitis and encephalitis : management and prevention challenges / Rodrigo Hasbun, editor  2018 1
 

Meningitis, Purulent -- See Meningitis, Cerebrospinal


  1
 

Meningitis, Suppurative -- See Meningitis, Cerebrospinal


  1
Meningitis -- therapy.   3
Meningitis -- Treatment   2
Meningitis -- Treatment -- Australia.   2
Meningitis -- United States -- Prevention : 60 minutes. Lethal medicine / produced by Michael Rey, Oriana Zill de Granados, and Michael Radutzky  2013 1
Meningitis -- Vaccination : Curbing the tide of meningitis / by Jago Smith  2010 1
Meningitis -- Vaccination -- Africa, Sub-Saharan : Immunization strategies : eradicating meningitis in Sub-Saharan Africa / Sarah Cruickshank and Samantha Grills  2012 1
 

Meningo-encephalomyelitis -- See Encephalomyelitis


  1
 

Meningococcal diseases -- See Meningococcal infections


  1
Meningococcal infections.   5
Meningococcal Infections -- diagnosis : Handbook of meningococcal disease management / Ian Feavers, Andrew J Pollard, Manish Sadarangani [editors]  2016 1
Meningococcal Infections -- prevention & control : Immunization strategies : eradicating meningitis in Sub-Saharan Africa / Sarah Cruickshank and Samantha Grills  2012 1
Meningococcal Infections -- therapy : Handbook of meningococcal disease management / Ian Feavers, Andrew J Pollard, Manish Sadarangani [editors]  2016 1
Meningococcal infections -- Treatment -- Handbooks, manuals, etc : Handbook of meningococcal disease management / Ian Feavers, Andrew J Pollard, Manish Sadarangani [editors]  2016 1
Meningococcal infections -- United States : Meningococcal disease among college-aged young adults, 2014-2016 / American Academy of Pediatrics  2018 1
Meningococcal infections -- Vaccination : Meningococcal disease among college-aged young adults, 2014-2016 / American Academy of Pediatrics  2018 1
Meningococcal infections -- Vaccination -- United States : Adoption of serogroup B meningococcal vaccine recommendations / American Academy of Pediatrics  2018 1
 

Meningococcal Meningitis -- See Meningitis, Meningococcal


A fulminant infection of the meninges and subarachnoid fluid by the bacterium NEISSERIA MENINGITIDIS, producing diffuse inflammation and peri-meningeal venous thromboses. Clinical manifestations include FEVER, nuchal rigidity, SEIZURES, severe HEADACHE, petechial rash, stupor, focal neurologic deficits, HYDROCEPHALUS, and COMA. The organism is usually transmitted via nasopharyngeal secretions and is a leading cause of meningitis in children and young adults. Organisms from Neisseria meningitidis serogroups A, B, C, Y, and W-135 have been reported to cause meningitis. (From Adams et al., Principles of Neurology, 6th ed, pp689-701; Curr Opin Pediatr 1998 Feb;10(1):13-8) 		  1
 

Meningococcal Meningitis, Serogroup A -- See Meningitis, Meningococcal


A fulminant infection of the meninges and subarachnoid fluid by the bacterium NEISSERIA MENINGITIDIS, producing diffuse inflammation and peri-meningeal venous thromboses. Clinical manifestations include FEVER, nuchal rigidity, SEIZURES, severe HEADACHE, petechial rash, stupor, focal neurologic deficits, HYDROCEPHALUS, and COMA. The organism is usually transmitted via nasopharyngeal secretions and is a leading cause of meningitis in children and young adults. Organisms from Neisseria meningitidis serogroups A, B, C, Y, and W-135 have been reported to cause meningitis. (From Adams et al., Principles of Neurology, 6th ed, pp689-701; Curr Opin Pediatr 1998 Feb;10(1):13-8) 		  1
 

Meningococcal Meningitis, Serogroup B -- See Meningitis, Meningococcal


A fulminant infection of the meninges and subarachnoid fluid by the bacterium NEISSERIA MENINGITIDIS, producing diffuse inflammation and peri-meningeal venous thromboses. Clinical manifestations include FEVER, nuchal rigidity, SEIZURES, severe HEADACHE, petechial rash, stupor, focal neurologic deficits, HYDROCEPHALUS, and COMA. The organism is usually transmitted via nasopharyngeal secretions and is a leading cause of meningitis in children and young adults. Organisms from Neisseria meningitidis serogroups A, B, C, Y, and W-135 have been reported to cause meningitis. (From Adams et al., Principles of Neurology, 6th ed, pp689-701; Curr Opin Pediatr 1998 Feb;10(1):13-8) 		  1
 

Meningococcal Meningitis, Serogroup C -- See Meningitis, Meningococcal


A fulminant infection of the meninges and subarachnoid fluid by the bacterium NEISSERIA MENINGITIDIS, producing diffuse inflammation and peri-meningeal venous thromboses. Clinical manifestations include FEVER, nuchal rigidity, SEIZURES, severe HEADACHE, petechial rash, stupor, focal neurologic deficits, HYDROCEPHALUS, and COMA. The organism is usually transmitted via nasopharyngeal secretions and is a leading cause of meningitis in children and young adults. Organisms from Neisseria meningitidis serogroups A, B, C, Y, and W-135 have been reported to cause meningitis. (From Adams et al., Principles of Neurology, 6th ed, pp689-701; Curr Opin Pediatr 1998 Feb;10(1):13-8) 		  1
 

Meningococcal Meningitis, Serogroup W-135 -- See Meningitis, Meningococcal


A fulminant infection of the meninges and subarachnoid fluid by the bacterium NEISSERIA MENINGITIDIS, producing diffuse inflammation and peri-meningeal venous thromboses. Clinical manifestations include FEVER, nuchal rigidity, SEIZURES, severe HEADACHE, petechial rash, stupor, focal neurologic deficits, HYDROCEPHALUS, and COMA. The organism is usually transmitted via nasopharyngeal secretions and is a leading cause of meningitis in children and young adults. Organisms from Neisseria meningitidis serogroups A, B, C, Y, and W-135 have been reported to cause meningitis. (From Adams et al., Principles of Neurology, 6th ed, pp689-701; Curr Opin Pediatr 1998 Feb;10(1):13-8) 		  1
 

Meningococcal Meningitis, Serogroup W135 -- See Meningitis, Meningococcal


A fulminant infection of the meninges and subarachnoid fluid by the bacterium NEISSERIA MENINGITIDIS, producing diffuse inflammation and peri-meningeal venous thromboses. Clinical manifestations include FEVER, nuchal rigidity, SEIZURES, severe HEADACHE, petechial rash, stupor, focal neurologic deficits, HYDROCEPHALUS, and COMA. The organism is usually transmitted via nasopharyngeal secretions and is a leading cause of meningitis in children and young adults. Organisms from Neisseria meningitidis serogroups A, B, C, Y, and W-135 have been reported to cause meningitis. (From Adams et al., Principles of Neurology, 6th ed, pp689-701; Curr Opin Pediatr 1998 Feb;10(1):13-8) 		  1
 

Meningococcal Meningitis, Serogroup Y -- See Meningitis, Meningococcal


A fulminant infection of the meninges and subarachnoid fluid by the bacterium NEISSERIA MENINGITIDIS, producing diffuse inflammation and peri-meningeal venous thromboses. Clinical manifestations include FEVER, nuchal rigidity, SEIZURES, severe HEADACHE, petechial rash, stupor, focal neurologic deficits, HYDROCEPHALUS, and COMA. The organism is usually transmitted via nasopharyngeal secretions and is a leading cause of meningitis in children and young adults. Organisms from Neisseria meningitidis serogroups A, B, C, Y, and W-135 have been reported to cause meningitis. (From Adams et al., Principles of Neurology, 6th ed, pp689-701; Curr Opin Pediatr 1998 Feb;10(1):13-8) 		  1
 

Meningococcal Polysaccharide Vaccine -- See Meningococcal Vaccines


Vaccines or candidate vaccines used to prevent infection with NEISSERIA MENINGITIDIS 		  1
 

Meningococcal Vaccine -- See Meningococcal Vaccines


Vaccines or candidate vaccines used to prevent infection with NEISSERIA MENINGITIDIS 		  1
 

Meningococcal Vaccine, Bivalent -- See Meningococcal Vaccines


Vaccines or candidate vaccines used to prevent infection with NEISSERIA MENINGITIDIS 		  1
 

Meningococcal Vaccine, Tetravalent -- See Meningococcal Vaccines


Vaccines or candidate vaccines used to prevent infection with NEISSERIA MENINGITIDIS 		  1
Meningococcal Vaccines.   3
 

Meningococcic meningitis -- See Meningitis, Cerebrospinal


  1
 

Meningococcus -- See Neisseria meningitidis


  1
Meningoencephalitis.   2
Meningokokken.   2
Add Marked to Bag Add All On Page Add Marked to My Lists
Result Page   Prev Next
Limit/Sort Search Search as Words